GSK Lays Off 650 Workers as It Shuts German Vaccine Manufacturing Site
NewsData.io · United States · Sep 15, 2026
GSK is closing its Dresden, Germany vaccine manufacturing facility and consolidating operations at its Canadian plant as part of a broader $2.5 billion cost-cutting campaign announced in July. The closure will result in approximately 650 job losses. The move is part of CEO Luke Miels' initiative to simplify the organization and redirect capital toward late-stage pipeline development. GSK has not yet disclosed the total headcount impact of its wider savings push.
Get the weekly brief by email
What changed in staffing last week, every Monday morning. Free. Unsubscribe anytime.
Related stories
A $500 billion wave of U.S…
Detroit ABC affiliate WXYZ-TV (Channel 7) has eliminated at least 30 positions through a combination of buyouts and layoffs, according to sources who…
Dole Packaged Foods will permanently close its Atwater, California processing facility and a nearby Livingston laboratory, eliminating 404 jobs in…
About 1,400 IRS IT employees displaced by DOGE-directed downsizing have been reorganized into 'ONE IRS Readiness' teams with no defined mission…